Abstract
We present a case of exon 20 insertion mutation (A763_764insFQEA), with documented clinical and radiological response to EGFR TKI. To our knowledge, this is the first report of response to erlotinib monotherapy with this particular solitary mutation.
Cite
CITATION STYLE
APA
Voon, P. J., Tsui, D. W. Y., Rosenfeld, N., & Chin, T. M. (2013). EGFR Exon 20 Insertion A763-Y764insFQEA and Response to Erlotinib—Letter. Molecular Cancer Therapeutics, 12(11), 2614–2615. https://doi.org/10.1158/1535-7163.mct-13-0192
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free